Role of thrombin in chronic rhinosinusitis-associated tissue remodeling

American Journal of Rhinology and Allergy

Volumn 25, Issue 1, 2011, Pages 7-11

  Shimizu, Shino ^a   Gabazza, Esteban C ^b   Ogawa, Takao ^a   Tojima, Ichiro ^a   Hoshi, Eriko ^a   Kouzaki, Hideaki ^a   Shimizu, Takeshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; VASCULOTROPIN;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOOD CLOTTING; CHRONIC INFLAMMATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; NOSE MUCOSA; NOSE POLYP; NOSE SECRETION; PATHOGENESIS; PROTEIN SECRETION; RESPIRATORY EPITHELIUM; RHINOSINUSITIS; TISSUE REPAIR;

ADULT; AGED; AIRWAY REMODELING; ASTHMA; BODILY SECRETIONS; CELL LINE; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; NOSE; RECEPTORS, THROMBIN; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79551508964     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3535     Document Type: Article

References (42)

1. Rothenberg M. VEGF obstructs the lungs. Nat Med 10:1041-1042, 2004.
2. Gosepath J, Brieger J, Lehr H, et al. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol 19:7-13, 2005.
3. Gabazza E, Taguchi O, Kamada H, et al. Progress in the understanding of protease-activated receptors. Int J Hematol 79:117-122, 2004.
4. Matthay M, and Clements J. Coagulation-dependent mechanisms and asthma. J Clin Invest 114:20-23, 2004.
5. Howell D, Laurent G, and Chambers R. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem Soc Trans 30:211-216, 2002.
6. Gabazza E, Taguchi O, Tamaki S, et al. Thrombin in the airways of asthmatic patients. Lung 177:253-262, 1999.
7. Shimizu S, Shimizu T, Morser J, et al. Role of the coagulation system in allergic inflammation in the upper airways. Clin Immunol 129:365-371, 2008.
8. Shimizu S, Gabazza E, Hayashi T, et al. Thrombin stimulates the expression of PDGF in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 279:L503-L510, 2000.
9. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care 12(suppl 6):S3, 2008.
10. Thomas M, Yawn B, Price D, et al. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - A summary. Prim Care Respir J 17:79-89, 2008.
11. Global Initiative for Asthma (GINA), National Heart, Lung, and Blood Institute (NHLBI) (Ed). Global strategy for asthma management and prevention. NHLBI Report, Bethesda, MD, 2006.
12. Committee of the Practical Guideline for the Management of Allergic Rhinitis (Ed). Examination and diagnosis. In Practical Guideline for the Management of Allergic Rhinitis in Japan. Tokyo: Life Science Publishing, 17-31, 2009.
13. Yamaguchi A, Gabazza E, Takei Y, et al. Role of thrombin in interleukin-5 expression from basophils. Biochem Biophys Res Commun 368:116-120, 2008.
14. Greiff L, Andersson M, Erjefält J, et al. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging 23:301-306, 2003.
15. Hernández-Rodríguez N, Cambrey A, Harrison N, et al. Role of thrombin in pulmonary fibrosis. Lancet 346:1071-1073, 1995.
16. Ramachandran R, and Hollenberg M. Proteinases and signaling: Pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153(suppl 1):S263-S282, 2008.
17. Mercer P, Johns R, Scotton C, et al. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am J Respir Crit Care Med 179:414-425, 2009.
18. Hayashi S, Takeuchi K, Suzuki S, et al. Effect of thrombin on permeability of human epithelial cell monolayers. Pharmacology 76:46-52, 2006. (Pubitemid 41759061)
19. Feistritzer C, Mosheimer B, Kaneider N, et al. Thrombin affects eosinophil migration via protease-activated receptor-1. Int Arch Allergy Immunol 135:12-16, 2004.
20. Lee C, Link H, Baluk P, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095-1103, 2004.
21. Matsune S, Ohori J, Sun D, et al. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis. Am J Rhinol 22:365-370, 2008.
22. Wittekindt C, Hess A, Bloch W, et al. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol 259:294-298, 2002.
23. Coste A, Brugel L, Maître B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J 15:367-372, 2000.
24. Koyama S, Sato E, Tsukadaira A, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J 20:1449-1456, 2002.
25. Huang Y, Li J, Hu L, et al. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 86:1094-1098, 2001.
26. Liu J, Schuff-Werner P, and Steiner M. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 343:183-189, 2006.
27. Haruna S, Shimada C, Ozawa M, et al. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology 47:66-71, 2009.
28. Haruna S, Nakanishi M, Otori N, et al. Histopathological features of nasal polyps with asthma association: An immunohistochemical study. Am J Rhinol 18:165-172, 2004.
29. Seybt M, McMains K, and Kountakis S. The prevalence and effect of asthma on adults with chronic rhinosinusitis. Ear Nose Throat J 86:409-411, 2007.
30. Steinke J. The relationship between rhinosinusitis and asthma sinusitis. Curr Allergy Asthma Rep 6:495-501, 2006.
31. Bateman N, Shahi A, Feeley K, et al. Vascular endothelial growth factor in nasal polyps: A comparison of asthmatic and non-asthmatic patients. Clin Otolaryngol Allied Sci 29:677-681, 2004. (Pubitemid 39557000)
32. Howell D, Goldsack N, Marshall R, et al. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 159:1383-1395, 2001.
33. Günther A, Lübke N, Ermert M, et al. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 168:1358-1365, 2003.
34. Idell S. The matrix unloaded: Aerosolized heparin or urokinase for pulmonary fibrosis. Am J Respir Crit Care Med 168:1268-1269, 2003.
35. Ahmed T, Garrigo J, and Danta I. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N Engl J Med 329:90-95, 1993.
36. Suchankova J, Mata M, Cortijo J, et al. Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats. Eur J Pharmacol 507:261-271, 2005.
37. Yasui H, Gabazza E, Tamaki S, et al. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 163:1660-1668, 2001.
38. Yuda H, Adachi Y, Taguchi O, et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood 103:2196-2204, 2004.
39. Shimizu S, Gabazza E, Taguchi O, et al. Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med 167:1416-1426, 2003.
40. Kijiyama N, Ueno H, Sugimoto I, et al. Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis. Biochem Biophys Res Commun 339:1113-1119, 2006.
41. Howell D, Johns R, Lasky J, et al. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 166:1353-1365, 2005.
42. Atzori L, Lucattelli M, Scotton C, et al. Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia. Am J Respir Cell Mol Biol 41:680-687, 2009.